Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C BORDEN

Showing results (251-260 of 327) with videos related to

Pageof 33
Sort By:
Journal of Interferon Research|December 1, 1992
Absence of biological effects of orally administered interferon-beta serP L Witt, D Goldstein, B E Storer, et al.
Medical and Pediatric Oncology|January 1, 1977
Hexamethylmelamine treatment of sarcomas and lymphomasE C Borden, P Larson, F J Ansfield, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|November 23, 2006
Short communication: phase I clinical and gene modulatory evaluation of tamoxifen and IFN-alpha2bSnehal G Thakkar, David Peereboom, Thomas Olencki, et al.
The Journal of Biological Chemistry|June 25, 2004
Natural soluble interleukin-15Ralpha is generated by cleavage that involves the tumor necrosis factor-alpha-converting enzyme (TACE/ADAM17)Vadim Budagian, Elena Bulanova, Zane Orinska, et al.
Annals of Internal Medicine|July 1, 1982
Leukocyte-derived interferon (alpha) in human breast carcinoma. The American Cancer Society phase II trialE C Borden, J F Holland, T L Dao, et al.
Cancer Research|November 1, 1993
Phase I trial of an oral immunomodulator and interferon inducer in cancer patientsP L Witt, P S Ritch, D Reding, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 14, 2003
Biologic activity of polyethylene glycol12000-interferon-alpha2b compared with interferon-alpha2b: gene modulatory and antigrowth effects in tumor cellsKeyur Vyas, Diana L Brassard, Marc M DeLorenzo, et al.
Metabolism: Clinical and Experimental|May 1, 1984
Decreases in serum high-density-lipoprotein cholesterol and total cholesterol resulting from naturally produced and recombinant DNA-derived leukocyte interferonsR M Dixon, E C Borden, N L Keim, et al.
Cancer Research|June 18, 2002
Interferon stimulated gene 15 constitutively produced by melanoma cells induces e-cadherin expression on human dendritic cellsElisabetta Padovan, Luigi Terracciano, Ulrich Certa, et al.
Oncotarget|December 29, 2011
Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effectsTaolin Yi, Paul Elson, Masato Mitsuhashi, et al.
Pageof 33

Showing results (251-260 of 327) with videos related to

Sort By:
Pageof 33
Journal of Interferon Research|December 1, 1992
Absence of biological effects of orally administered interferon-beta serP L Witt, D Goldstein, B E Storer, et al.
Medical and Pediatric Oncology|January 1, 1977
Hexamethylmelamine treatment of sarcomas and lymphomasE C Borden, P Larson, F J Ansfield, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|November 23, 2006
Short communication: phase I clinical and gene modulatory evaluation of tamoxifen and IFN-alpha2bSnehal G Thakkar, David Peereboom, Thomas Olencki, et al.
The Journal of Biological Chemistry|June 25, 2004
Natural soluble interleukin-15Ralpha is generated by cleavage that involves the tumor necrosis factor-alpha-converting enzyme (TACE/ADAM17)Vadim Budagian, Elena Bulanova, Zane Orinska, et al.
Annals of Internal Medicine|July 1, 1982
Leukocyte-derived interferon (alpha) in human breast carcinoma. The American Cancer Society phase II trialE C Borden, J F Holland, T L Dao, et al.
Cancer Research|November 1, 1993
Phase I trial of an oral immunomodulator and interferon inducer in cancer patientsP L Witt, P S Ritch, D Reding, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 14, 2003
Biologic activity of polyethylene glycol12000-interferon-alpha2b compared with interferon-alpha2b: gene modulatory and antigrowth effects in tumor cellsKeyur Vyas, Diana L Brassard, Marc M DeLorenzo, et al.
Metabolism: Clinical and Experimental|May 1, 1984
Decreases in serum high-density-lipoprotein cholesterol and total cholesterol resulting from naturally produced and recombinant DNA-derived leukocyte interferonsR M Dixon, E C Borden, N L Keim, et al.
Cancer Research|June 18, 2002
Interferon stimulated gene 15 constitutively produced by melanoma cells induces e-cadherin expression on human dendritic cellsElisabetta Padovan, Luigi Terracciano, Ulrich Certa, et al.
Oncotarget|December 29, 2011
Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effectsTaolin Yi, Paul Elson, Masato Mitsuhashi, et al.
Pageof 33